USPTO serial 79328096
LAVA THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 24, 2023
- Examiner
- MASON, JARED MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LAVA THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert R. Baron, Jr.
Robert R. Baron, Jr. Ballard Spahr LLP1735 Market St. 51st FloorPhiladelphia, PA 19103UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Antibodies for scientific and research use; proteins, enzymes, diagnostic reagents, and chemical and biochemical preparations and substances for use in the manufacture of medicines | ACTIVE | — |
| 005 | Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment or diagnosis of cancer, autoimmune diseases and immunological disorders | ACTIVE | — |
| 042 | Bio-technology and scientific services, namely, scientific and medical research and development services relating to bio-technology and science in the field of antibodies, proteins and enzymes; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, namely, scientific and medical research in the fields of antibodies, protein and enzyme evolving services; biochemistry research services, namely, scientific and medical research in the fields of antibodies, protein and enzyme cataloging and antibodies, protein and enzyme library services; scientific and medical laboratory services relating to the production of antibodies, proteins and enzymes | ACTIVE | — |
| 044 | Providing health information about the treatment or diagnosis of cancer, autoimmune diseases and immunological disorders via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Lava Therapeutics N.V.
- Other trademarks owned by Lava Therapeutics N.V.
- Other trademarks owned by Lava Therapeutics N.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LAVA THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 23, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 3, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 3, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 24, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 24, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 24, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 9, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 19, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 3, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 20, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 22, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 26, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 26, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 23, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 22, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 4, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 26, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 19, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 19, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 19, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 19, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 14, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |